Annexin II Overexpression Predicts Rapid Recurrence after Surgery in Pancreatic Cancer Patients Undergoing Gemcitabine-Adjuvant Chemotherapy

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of Surgical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1245/s10434-008-0061-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

  2023cited by this paper
• Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells

  2008cited by this paper
• Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial

  2008cited by this paper
• Involvement of Annexin A2 in p53 induced apoptosis in lung cancer

  2008cited by this paper
• Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

  2007influential reference
• Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.

  2007cited by this paper
• The role of gemcitabine in first-line treatment of advanced ovarian carcinoma.

  2006cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin

  2006cited by this paper
• Tenascin C and annexin II expression in the process of pancreatic carcinogenesis

  2006cited by this paper
• Immunohistochemical and Genetic Evaluation of Deoxycytidine Kinase in Pancreatic Cancer: Relationship to Molecular Mechanisms of Gemcitabine Resistance and Survival

  2006cited by this paper
• Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance

  2006cited by this paper
• Current state of adjuvant therapy in resected pancreatic adenocarcinoma

  2006cited by this paper
• Chemotherapeutic gemcitabine doublets in pancreatic carcinoma.

  2005cited by this paper
• Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape.

  2005influential reference
• Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro

  2004cited by this paper
• Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages.

  2004cited by this paper
• Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis

  2004cited by this paper
• Classification of Pancreatic Cancer: Comparison of Japanese and UICC Classifications

  2004cited by this paper
• Establishment of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Effect of Brefeldin-A on the Resistant Cell Line

  2003cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells.

  2002cited by this paper
• Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial

  2001cited by this paper
• Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma.

  2001cited by this paper
• Annexin II overexpression correlates with stromal tenascin‐C overexpression

  2001cited by this paper
• Preparative two‐dimensional gel electrophoresis with agarose gels in the first dimension for high molecular mass proteins

  2000cited by this paper
• Annexin II and bleeding in acute promyelocytic leukemia.

  1999cited by this paper
• Annexin II: a mediator of the plasmin/plasminogen activator system.

  1999cited by this paper
• The role of gemcitabine in the treatment of other tumours.

  1998cited by this paper
• Expression of annexin II in glioma cell lines and in brain tumor biopsies

  1998cited by this paper
• Polarized localizations of annexins I, II, VI and XIII in epithelial cells of intestinal, hepatic and pancreatic tissues.

  1998cited by this paper
• New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.

  1998cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• Annexin II: A Novel Mediator of Cell Surface Plasmin Generation

  1997cited by this paper
• Preparative two‐dimensional gel electrophoresis of membrane proteins

  1997cited by this paper
• National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer.

  1996cited by this paper
• Annexin II marks astrocytic brain tumors of high histologic grade.

  1994cited by this paper
• An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.

  1994cited by this paper
• Differential expression of annexins I and II in normal and malignant human mammary epithelial cells.

  1993cited by this paper
• Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.

  1992cited by this paper
• Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts.

  1992cited by this paper
• Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma.

  1990cited by this paper
• Diversity in the lipocortin/calpactin family.

  1988cited by this paper
• Ca2+-dependent phospholipid- (and membrane-) binding proteins.

  1988cited by this paper

• Annexin A2 in Tumors of the Gastrointestinal Tract, Liver, and Pancreas

  2024cites this paper
• Annexin A2: the feasibility of being a therapeutic target associated with cancer metastasis and drug resistance in cancer microenvironment

  2024cites this paper
• A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2

  2022cites this paper
• Annexin A2 and Kidney Diseases

  2022cites this paper
• Advances in cancer treatment: a new therapeutic target, Annexin A2

  2021cites this paper
• Dimethylaminomicheliolide (DMAMCL) Inhibits Cell Proliferation and Increases Apoptosis and Efficacy of Gemcitabine via Annexin A2 in Pancreatic Adenocarcinoma

  2021cites this paper
• Radiation engenders converse migration and invasion in colorectal cancer cells through opposite modulation of ANXA2/AKT/GSK3β pathway.

  2021cites this paper
• Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells

  2019cites this paper
• Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism

  2019cites this paper
• High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma.

  2019cites this paper
• Identification of natural compounds targeting Annexin A2 with an anti-cancer effect

  2018cites this paper
• Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer

  2018influential citation
• Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma

  2018cites this paper
• The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma

  2018cites this paper
• Immune‐complex level of cofilin‐1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer

  2017cites this paper
• RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway

  2015cites this paper
• Association of annexin A2 with cancer development (Review).

  2015cites this paper
• Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer

  2015cites this paper
• Investigating the role of Annexin A2 in Epidermal Growth Factor (EGF) induced signalling in cancer

  2015cites this paper
• Role of annexin A2 in ovarian cancer metastasis.

  2014cites this paper
• Potential Prognostic Biomarkers of Pancreatic Cancer

  2014cites this paper
• Annexin A2 Heterotetramer: Structure and Function

  2013cites this paper
• Development of multidisciplinary therapy including surgical resection and chemotherapy for pancreatic cancer through clinical trials

  2013cites this paper
• Annexin A2: The Importance of Being Redox Sensitive

  2013cites this paper
• Three are better than one: plasminogen receptors as cancer theranostic targets

  2013influential citation
• Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer

  2012cites this paper
• Overexpression of Annexin A2 Is Associated with Abnormal Ubiquitination in Breast Cancer

  2012cites this paper
• Up‐regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF‐7 cells

  2012cites this paper
• Extracellular Release of Annexin II From Pancreatic Cancer Cells and Resistance to Anticancer Drug–Induced Apoptosis by Supplementation of Recombinant Annexin II

  2012cites this paper
• Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.

  2012cites this paper
• An Effective Vaccine Strategy of Translating Apoptotic Tumor Cells into Cancer Vaccine

  2012cites this paper
• Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis

  2011cites this paper
• The Role of Annexin A2 in Tumorigenesis and Cancer Progression

  2011influential citation
• Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer

  2011cites this paper
• A Functional Proteomic Method for Biomarker Discovery

  2011cites this paper
• Other than IPG‐DALT: 2‐DE variants

  2010cites this paper
• Annexin A 2 and cancer : A systematic review

  year unknowncites this paper